Peter Rappl CEO PENGUINBIO

PENGUINBIO

PENGUINBIO

PENGUINBIO offers the first molecular test enabling early detection of gut barrier disruption and preventing diseases before they arise.

Developed for astronauts, designed to protect human health on Earth.

The gut barrier is the body’s unseen frontier. It regulates what enters and what stays out. 

In astronauts, this delicate balance collapses under spaceflight stressors such as microgravity and radiation.

PENGUINBIO offers the first molecular test that detects these early disruptions. Enabling targeted prevention both in orbit and on Earth.

Developed within ESA BIC and Space2Health to monitor astronaut health in microgravity, and translating space health into preventative diagnostics for over a billion people on Earth.

our technology

We identified a key modulator of intestinal tight junctions. Our proprietary antibody binds with high specificy, detecting early barrier disruption before inflammation occurs.

Using small serum volumes, our test provides quantitative readouts that reveal subtle changes in gut permeability.

Validated in astronauts and clinical cohorts, our platform enables precision prevention. Bridging space medicine and global health.

partners & programes

PENGUINBIO is proudly supported by the European Space Agency Business Incubation Centre (ESA BIC Hessen & BaWü), push! Stipendium Hessen, and is a member of the Space2Health initiative.

With additional partners and academic collaborators, we accelerate our journey.

behind PENGUINBIO

  • peter rappl

    founder, ceo & scientific lead

  • desiree schröder

    shareholder

Contact us via hello@penguinbio.com , if you are:

  • A biobank with access to astronaut samples or other applicable cohorts to support our validation

  • An assay developer in the IVDR landscape

  • An investor willing to accelerate our market entry

  • or you know someone of the above or consider yourself a sparring partner with similar scientific discoveries related to gut health

If you are you none of the above but still want to support us, donate today, follow us

and help amplify our idea through visibility.

support us.

3 % Gebührendeckung